BPMX - BioPharmX Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
1/30/2019
1/30/2018
1/30/2017
1/30/2016
Cash flows from operating activities
Net Income
-14,715
-17,258
-16,640
-18,406
-15,598
Depreciation & amortization
59
62
52
260
86
Deferred income taxes
-
-
-
-
-
Stock based compensation
1,390
2,061
1,887
1,491
1,214
Change in working capital
-1,127
-706
-673
927
1,248
Accounts receivable
-
-
-3
3
-6
Inventory
-
-
28
62
60
Accounts Payable
-589
-13
-1,175
774
625
Other working capital
-13,667
-15,035
-15,628
-15,791
-12,652
Other non-cash items
-
3
151
145
436
Net cash provided by operating activites
-13,598
-14,992
-15,587
-15,746
-12,614
Cash flows from investing activities
Investments in property, plant and equipment
-69
-43
-41
-45
-38
Acquisitions, net
-
-
-
-
-
Purchases of investments
-
-
-
-
-
Sales/Maturities of investments
-
-
-
-
-
Other investing activites
-
-
-
0
0
Net cash used for investing activites
-69
-43
-41
-45
-38
Cash flows from financing activities
Debt repayment
-24
-19
-
-
-
Common stock issued
6,811
0
16,049
16,712
13,316
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
-
0
1,487
Net cash used privided by (used for) financing activities
10,376
10,528
16,703
18,253
15,386
Net change in cash
-3,291
-4,507
1,075
2,462
2,734
Cash at beginning of period
6,581
7,576
6,501
4,039
1,305
Cash at end of period
3,290
3,069
7,576
6,501
4,039
Free Cash Flow
Operating Cash Flow
-13,598
-14,992
-15,587
-15,746
-12,614
Capital Expenditure
-69
-43
-41
-45
-38
Free Cash Flow
-13,667
-15,035
-15,628
-15,791
-12,652